Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
November 02, 2023 at 04:08 am EDT
Share
Dr. Lal PathLabs Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 6,013 million compared to INR 5,338 million a year ago. Revenue was INR 6,194 million compared to INR 1,426 million a year ago. Net income was INR 1,093 million compared to INR 717 million a year ago. Basic earnings per share from continuing operations was INR 13.16 compared to INR 8.64 a year ago. Diluted earnings per share from continuing operations was INR 13.12 compared to INR 8.6 a year ago.
For the six months, sales was INR 11,423 million compared to INR 10,365 million a year ago. Revenue was INR 11,748 million compared to INR 10,535 million a year ago. Net income was INR 1,919 million compared to INR 1,294 million a year ago. Basic earnings per share from continuing operations was INR 23.11 compared to INR 15.61 a year ago. Diluted earnings per share from continuing operations was INR 23.05 compared to INR 15.55 a year ago.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
